Zobrazeno 1 - 10
of 31
pro vyhledávání: '"He-Rui Yao"'
Autor:
Guo-Ying Liu, Nian Lu, Wei-Xin Bei, Wang-Zhong Li, Hu Liang, Wei-Xiong Xia, Yan-Qun Xiang, He-Rui Yao
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundWe aimed to establish a prognostic model to identify suitable candidates for chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) patients.Patients and methodsIn this retrospective study, we included 524 pati
Externí odkaz:
https://doaj.org/article/7f9bf4e7f50042ba8469bb5eaa7d7621
Autor:
Guo-Ying Liu, Wei-Xiong Xia, Zhuo-Fei Bi, Nian Lu, Wang-Zhong Li, Wei-Xin Bei, Hu Liang, Jun-Zhi Xie, Yi-Min Liu, He-Rui Yao, Yan-Qun Xiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPlasma Epstein–Barr virus DNA (EBV-DNA) is a sensitive and specific biomarker for nasopharyngeal carcinoma (NPC). We investigated whether longitudinal monitoring of EBV-DNA could accurately detect clinical disease progression in NPC patie
Externí odkaz:
https://doaj.org/article/9526841f163241669358b77e1d5df611
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Long noncoding RNAs (lncRNAs) actively participate in breast cancer (BRCA) tumorigenesis via epigenetic mechanisms. Our study identified immune-related lncRNA (irlncRNA) pairs and compiled them into a set of noncoding gene signatures able to stratify
Externí odkaz:
https://doaj.org/article/b6cdf685c46d4b968e896077ca004065
Autor:
Kai-yun You MD, Zhuo-fei Bi MD, Yu-jia Ma BD, Yong-lin Mao BD, Wei-liang Zou BD, Yi-min Liu MD, He-rui Yao MD
Publikováno v:
Cancer Control, Vol 28 (2021)
Purpose: Although breast conservation surgery(BCS) followed by adjuvant radiotherapy is now the mainstream treatment method for breast ductal carcinoma in situ(DCIS), mastectomy is still performed in some patients who refuse to undergo radiation. How
Externí odkaz:
https://doaj.org/article/c470872ac4de453380053c6075ead4a8
Autor:
Hai-Yu Zhou, Shao-Peng Zheng, An-Lin Li, Quan-Long Gao, Qi-Yun Ou, Yong-Jian Chen, Shao-Tao Wu, Da-Gui Lin, Sheng-Bo Liu, Lu-Yu Huang, Fa-Sheng Li, Hong-Yuan Zhu, Gui-Bin Qiao, Michael Lanuti, He-Rui Yao, Yun-Fang Yu
Publikováno v:
EClinicalMedicine, Vol 24, Iss , Pp 100422- (2020)
Background: The efficacy and safety of neoadjuvant treatment over surgery alone and that of neoadjuvant chemoradiotherapy (NCRT) over neoadjuvant chemotherapy (NCT) in resectable esophageal carcinoma remains inconclusive. This study (NewEC) used glob
Externí odkaz:
https://doaj.org/article/7738f986b5b04c248a566990b9e5e20b
Publikováno v:
Archives of Gynecology and Obstetrics. 307:891-901
To evaluate the effects of adjuvant chemotherapy (CT) and radiotherapy (RT) on the survival of uterine carcinosarcoma (UCS) patients.We analyzed 3207 patients with uterine carcinosarcoma without distant metastasis after surgery from 2004 to 2015 by u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c345e150ff500f3bdb8556a1b5bd3e08
https://doi.org/10.1007/s00404-022-06589-y
https://doi.org/10.1007/s00404-022-06589-y
Autor:
Louis Wing-Cheong, Chow, Pei-Fen, Fu, Lei, Guo, Xi-Chun, Hu, Jun, Jiang, Erich Ferdiansyah, Lie, Jian, Liu, Xiao-Hong, Lu, Yong-Kui, Lu, Hong-Min, Ma, Qin-Guo, Mo, Yan-Xia, Shi, Kun, Wang, Ming-Hao, Wang, Shu, Wang, Shu-Sen, Wang, Xian-Ming, Wang, Xiao-Jia, Wang, Hui-Jing, Wu, Hong-Jian, Yang, He-Rui, Yao, Yi, Zhang, Li, Zhu, On Behalf Of The Asian Institute Of Clinical Oncology Aico Expert Panel
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:379-382
There are varying definitions of women at high risk of breast cancer across different institutions, and there are reports suggesting that the breast cancer risk assessment tools have not been well integrated into clinical practice. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c598dba5aceaf46d75c81ba63c13eba
https://doi.org/10.31557/apjcp.2022.23.2.379
https://doi.org/10.31557/apjcp.2022.23.2.379
Autor:
Jian-Li Zhao, Xiao-Xiao Dinglin, Ya-Ping Yang, Si-Min Luo, Yang-Yang Cai, Jie Chai, Dong-Geng Liu, Ying Wang, He-Rui Yao
Publikováno v:
Journal of Clinical Oncology. 40:e13015-e13015
e13015 Background: Eribulin is a non-taxane microtubule inhibitor, which was approved for the third-line treatment of advanced breast cancer (ABC) in China in 2019. However, the efficacy and safety data of eribulin for the ABC in Chinese patients is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::020c0cae6218f567aa35f5b2cd5224be
https://doi.org/10.1200/jco.2022.40.16_suppl.e13015
https://doi.org/10.1200/jco.2022.40.16_suppl.e13015
Autor:
Ji Wen Wang, Hai Peng Xiao, Hui Zhang, Min Liu, Shu Yuan Cheng, Yu Tian Cong, Yu Qi Zhou, Ming Kuang, Han Xiao, Sui Peng, Da Ya Yang, Ke Wei Xu, Kar Keung Cheng, Shou Zhen Cheng, He Rui Yao, Fan Fan Hou, Qing Tang Zhu, Yang Yang
Publikováno v:
BMJ
The BMJ
The BMJ
ObjectiveTo examine the protective effects of appropriate personal protective equipment for frontline healthcare professionals who provided care for patients with coronavirus disease 2019 (covid-19).DesignCross sectional study.SettingFour hospitals i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7610a8547b604ebadaef0e5db378e4c3
Publikováno v:
Cancer Management and Research
Background Due to the low rate of regional recurrence (RR) in early-stage breast cancer with pT1-2 and negative sentinel lymph node biopsy (SLNB), no regional therapy is suggested for them. However, whether there is a subset of patients who were with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9cee9a164fb5e45f94853a58b129f755
https://pubmed.ncbi.nlm.nih.gov/33061612
https://pubmed.ncbi.nlm.nih.gov/33061612